Trials / Completed
CompletedNCT01423019
A Comparative Effectiveness Study Evaluating the Effects of Thermogenic Supplements on Body Composition
A Comparative Effectiveness Study Evaluating the Effects of Two Thermogenic Supplements on Body Composition Using a Double-Blinded Placebo-Controlled Protocol
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- Integrative Health Technologies, Inc. · Network
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether subjects taking a supplement designed to increase metabolic rate will have a positive effect on body composition (fat mass, muscle mass, and bone density.)
Detailed description
In a previous randomized double-blinded placebo-controlled pilot study, subjects taking the nutritional supplements contained in these two weight loss plans had a short-term statistically significant increase in their resting metabolic rates as compared to taking a placebo. No increases were found in blood pressure, resting heart rate, or self-reported discomfort when taking the supplement. The current study was designed to extend the findings of the pilot study over a 60-day study period using a randomized double-blinded placebo-controlled protocol with the same weight loss interventions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Advantra Z | Two capsules are taken twice daily, 20-30 minutes before breakfast and evening meals. Two capsules contain a total of 50 mg p-synephrine. |
| DIETARY_SUPPLEMENT | Advantra Z + Naringin + Hesperiden | Two capsules are taken twice daily, 20-30 minutes before breakfast and evening meals. Two capsules contain a total of 50 mg p-synephrine, 600 mg naringin, and 100 mg hesperiden. |
| OTHER | Sugar pill | Two capsules containing inert ingredients are taken twice daily, 20-30 minutes before breakfast and evening meals. |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2011-08-25
- Last updated
- 2012-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01423019. Inclusion in this directory is not an endorsement.